Über das Unternehmen
- Firmenname (rechtlich): Xi'an Caiiing Opto-Electrical Science & Technology Co., Ltd.
- Internationaler Name: 西安彩晶光电科技股份有限公司 (Xi'an Caijing Opto-Electrical Science & Technology Co., Ltd.), Xi'an, Shaanxi, China
- Marke / Handelsname: Caijing Opto-Electrical
- Registrierungsland: China
- Adresse: ShaanxiXi'anNo. 19, North Section of Weihua Road, Jingwei New Town, Economic and Technological Development Zone, Xi'an City, Shaanxi Province • Shaanxi
- Gründungsjahr: 2008
Beschreibung:
Xi'an Caiiing Opto-Electrical Science & Technology Co., Ltd, established in 2008, is a manufacturer and exporter of chiral intermediates and other fine chemicals used in pharmaceutical synthesis. Based in Xi'an's Economic and Technological Development Zone, the company offers CMO contract manufacturing and ships on FOB terms with D/P payment to customers across North America, Europe, Asia, the Middle East, Africa, and Australasia, competing on brand recognition, international certification, experienced R&D staff, and a broad product line while accommodating buyer specifications and small orders.
Geschäftsaktivitäten
Pharmazeutische Chemikalien
LieferantHersteller von SpezialchemikalienHerstellerExporteur
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon
Hauptprodukte/-dienstleistungen
- Pharmazeutische Chemikalien: Trans-4-(4-vinyl-cyclohexyl)-benzonitrile, Benzo[1,2-b:4,5-b']dithiophene-4,8-dione, 1,2,3-Trifluoro-5-[4’-propyl[1,1’-bicyclohexyl]-4-yl]benzene, 4-[4’-propyl[1,1’-bicyclohexyl]-4-yl]-1,2-difluorobenzene, 1’-Biphenyl2,3’,4’,5’-tetrafluor-4(trans-4-propylcyclohexyl), 1-Hydroxybut-2-yne, 1-Methyl-4-(4-trans-vinyl-[1,1′-bicyclohexyl]-4′-trans-yl)-benzol, 1,1'-Bicyclohexyl, 4-butyl-4'-propyl-, (trans,trans)-, 1,1'-Bicyclohexyl,4-ethyl-4'-propyl-, (trans,trans)-, 1,1′-Biphenyl, 2,3′,4′,5′-tetrafluor-4-(trans-4-propylcyclohexyl)-, 1,1':4',1''-TERPHENYL, 2'-FLUORO-4-PENTYL-4''-PROPYL-, 1,1':4',1''-TERPHENYL,2',3,4,5-TETRAFLUORO-4''-PROPYL-, 1,2,3-Trifluoro-5-(trans-4-pentylcyclohexyl)benzene, 1,5-Dinitronaphthalene, 1,8-Dinitronaphthalene, 1,8-Naphthalenediamine, 1PHH2V, 2-(3-Aminophenyl)-N-methylacetamide, 2-Chloro-6-iodoaniline, 2-(Dimethylamino)-2-phenylbutanol, 2-Fluoro-4-(trans-propylcyclohexyl)phenyl boronic acid, 2,3-dichloromaleic anhydride, 3-Iodobenzenamine, 3,4-Dichloraniline, 3,4,5-Trifluorophenol, 3,4,5-Trifluorophenylboronic acid, 4-[2-(Trans-4-pentylcyclohexyl)ethyl]cyclohexanone, 4-[2-(Trans-4-propylcyclohexyl)ethyl]cyclohexanone, 4'-(3,4-Difluorophenyl)bi(cyclohexan)-4-one, 4-[4-[1-(E)-propenyl]cyclohexyl]-, trans-Benzonitrile, 4-(4-Acryloyloxybutoxy)benzoic acid (ABBA), 4'-(4-Fluorophenyl)bi(cyclohexan)-4-one, 4-(6-(acryloyloxy)hexyloxy)benzoic acid, 4-Bromo-3',4',5'-trifluorobiphenyl, 4'-butylbi(cyclohexan)-4-one, 4-Ethenyl-4'-propyl-1,1'-bicyclohexyl, 4-Ethylbenzaldehyde, 4-Ethylcyclohexanone, 4-HYDROXYCYCLOHEXANONE, 4-Pentylbenzeneboronic acid, 4'-pentylbi(cyclohexan)-4-one, 4''-PROPYL-3-FLUOROBIPHENYL-4-BORONIC ACID, 4'-Propylbi(cyclohexan)-4-one, 4-Propylphenyl boronic acid, [4-(TRANS-4-N-PROPYLCYCLOHEXYL)PHENYL]BORONIC ACID, 4''-(TRANS-4-PROPYLCYCLOHEXYL)-3,4,5-TRIFLUORO-BIPHENYL, 4-(trans-4-propylcyclohexyl)benzoic acid, 4-[trans-4-(trans-4-Ethylcyclohexyl)cyclohexyl]-1-trifluoromethoxybenzene, 4,4,4-Trifluorobutanol, 5-Norbonene-2-carboxylic acid methyl ester, 5-Vinyl-2-pyrrolidinone, 5,8-Dihydronaphthalen-1-ol, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane, Asarone;2,4,5-Trimethoxy-1-propenylbenzene, Bicyclohexyl, Canagliflozin Intermediates, Caronic anhydride, Dicyclohexyl-3,4,3’,4’-tetracarboxylic dianhydride, HEXAFLUOROACETYLACETONE, Methyl 4-hydroxy-3-iodobenzoate, N-2-Cyanoethylbutane-1,4-diamine, N,N-Dimethyltrimethylsilylamine, trans-4-(3,4-Difluorophenyl)-trans-4'-vinylbicyclohexane, TRANS-4-(4-PROPYLCYCLOHEXYL)-4, Trans-4-ethyldicyclohexylanone, TRANS-4-N-PROPYLCYCLOHEXANOL, trans-4-propyl-(1,1-bicyclohexyl)-4-carboxylic acid, trans-4-(trans-4-Pentylcyclohexyl)cyclohexanol, trans-4’(4-n-Propylcyclohexyl)-3,4-difluor-1,1‘-biphenyl, TRANS,TRANS-4-(4-FLUOROPHENYL)-4’’-PROPYL-BICYCLOHEXYL, Trans,Trans-4''-(4''-propyl-bicyclohexyl-4-yl)--3,4,5-trifluorobiphenyl, TRANS,TRANS-4-BUTYL-4''-VINYL-BICYCLOHEXYL, TRANS,TRANS-4''-PENTYL-4-PROPYL-BICYCLOHEXYL, TRANS,TRANS-4-PENTYL-4''-VINYL-BICYCLOHEXYL, Trans,trans-4-propenyl-4''-propyl-bicyclohexyl, Trioctoxyborane, Liquid crystal materials, Flurbiprofen intermediates, Fluorinated speciality chemicals
Unsere Produkte & Dienstleistungen
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
![6,6-Dimethyl-3-azabicyclo[3.1.0]hexane](/_next/image?url=https%3A%2F%2Fapi.pharmacountry.com%2Fuploads%2Fitems%2F66-dimethyl-3-azabicyclo310hexane-226168.jpg&w=640&q=75)
Sell · Pharma Chemicals
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen